Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | P4HTM | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | LAMTOR2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | THEM4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | LEPR | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | LYSMD1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | SNX27 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | LATS1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | GAGE10 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | ZNF302 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | CYB5D1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |